Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1958 1
1959 1
1961 1
1966 2
1970 1
1995 2
1997 1
1999 2
2001 3
2003 1
2004 2
2005 3
2006 2
2007 1
2008 2
2009 4
2010 6
2011 9
2012 5
2013 5
2014 6
2015 6
2016 7
2017 9
2018 15
2019 11
2020 21
2021 13
2022 4
Text availability
Article attribute
Article type
Publication date

Search Results

125 results
Results by year
Filters applied: . Clear all
Page 1
Paediatric multiple sclerosis: a new era in diagnosis and treatment.
Duignan S, Brownlee W, Wassmer E, Hemingway C, Lim M, Ciccarelli O, Hacohen Y. Duignan S, et al. Among authors: hemingway c. Dev Med Child Neurol. 2019 Sep;61(9):1039-1049. doi: 10.1111/dmcn.14212. Epub 2019 Apr 1. Dev Med Child Neurol. 2019. PMID: 30932181 Free article. Review.
E.U. paediatric MOG consortium consensus: Part 5 - Treatment of paediatric myelin oligodendrocyte glycoprotein antibody-associated disorders.
Bruijstens AL, Wendel EM, Lechner C, Bartels F, Finke C, Breu M, Flet-Berliac L, de Chalus A, Adamsbaum C, Capobianco M, Laetitia G, Hacohen Y, Hemingway C, Wassmer E, Lim M, Baumann M, Wickström R, Armangue T, Rostasy K, Deiva K, Neuteboom RF. Bruijstens AL, et al. Among authors: hemingway c. Eur J Paediatr Neurol. 2020 Nov;29:41-53. doi: 10.1016/j.ejpn.2020.10.005. Epub 2020 Nov 4. Eur J Paediatr Neurol. 2020. PMID: 33176999 Free article. Review.
E.U. paediatric MOG consortium consensus: Part 1 - Classification of clinical phenotypes of paediatric myelin oligodendrocyte glycoprotein antibody-associated disorders.
Bruijstens AL, Lechner C, Flet-Berliac L, Deiva K, Neuteboom RF, Hemingway C, Wassmer E; E.U. paediatric MOG consortium, Baumann M, Bartels F, Finke C, Adamsbaum C, Hacohen Y, Rostasy K. Bruijstens AL, et al. Among authors: hemingway c. Eur J Paediatr Neurol. 2020 Nov;29:2-13. doi: 10.1016/j.ejpn.2020.10.006. Epub 2020 Nov 4. Eur J Paediatr Neurol. 2020. PMID: 33162302 Free article. Review.
Treatment of MOG-IgG-associated disorder with rituximab: An international study of 121 patients.
Whittam DH, Cobo-Calvo A, Lopez-Chiriboga AS, Pardo S, Gornall M, Cicconi S, Brandt A, Berek K, Berger T, Jelcic I, Gombolay G, Oliveira LM, Callegaro D, Kaneko K, Misu T, Capobianco M, Gibbons E, Karthikeayan V, Brochet B, Audoin B, Mathey G, Laplaud D, Thouvenot E, Cohen M, Tourbah A, Maillart E, Ciron J, Deschamps R, Biotti D, Rostasy K, Neuteboom R, Hemingway C, Forsyth R, Matiello M, Webb S, Hunt D, Murray K, Hacohen Y, Lim M, Leite MI, Palace J, Solomon T, Lutterotti A, Fujihara K, Nakashima I, Bennett JL, Pandit L, Chitnis T, Weinshenker BG, Wildemann B, Sato DK, Kim SH, Huda S, Kim HJ, Reindl M, Levy M, Jarius S, Tenembaum S, Paul F, Pittock S, Marignier R, Jacob A. Whittam DH, et al. Among authors: hemingway c. Mult Scler Relat Disord. 2020 Sep;44:102251. doi: 10.1016/j.msard.2020.102251. Epub 2020 Jun 2. Mult Scler Relat Disord. 2020. PMID: 32629363 Free PMC article.
Clinical presentation and prognosis in MOG-antibody disease: a UK study.
Jurynczyk M, Messina S, Woodhall MR, Raza N, Everett R, Roca-Fernandez A, Tackley G, Hamid S, Sheard A, Reynolds G, Chandratre S, Hemingway C, Jacob A, Vincent A, Leite MI, Waters P, Palace J. Jurynczyk M, et al. Among authors: hemingway c. Brain. 2017 Dec 1;140(12):3128-3138. doi: 10.1093/brain/awx276. Brain. 2017. PMID: 29136091
Disease Course and Treatment Responses in Children With Relapsing Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease.
Hacohen Y, Wong YY, Lechner C, Jurynczyk M, Wright S, Konuskan B, Kalser J, Poulat AL, Maurey H, Ganelin-Cohen E, Wassmer E, Hemingway C, Forsyth R, Hennes EM, Leite MI, Ciccarelli O, Anlar B, Hintzen R, Marignier R, Palace J, Baumann M, Rostásy K, Neuteboom R, Deiva K, Lim M. Hacohen Y, et al. Among authors: hemingway c. JAMA Neurol. 2018 Apr 1;75(4):478-487. doi: 10.1001/jamaneurol.2017.4601. JAMA Neurol. 2018. PMID: 29305608 Free PMC article.
Utility and safety of rituximab in pediatric autoimmune and inflammatory CNS disease.
Dale RC, Brilot F, Duffy LV, Twilt M, Waldman AT, Narula S, Muscal E, Deiva K, Andersen E, Eyre MR, Eleftheriou D, Brogan PA, Kneen R, Alper G, Anlar B, Wassmer E, Heineman K, Hemingway C, Riney CJ, Kornberg A, Tardieu M, Stocco A, Banwell B, Gorman MP, Benseler SM, Lim M. Dale RC, et al. Among authors: hemingway c. Neurology. 2014 Jul 8;83(2):142-50. doi: 10.1212/WNL.0000000000000570. Epub 2014 Jun 11. Neurology. 2014. PMID: 24920861 Free PMC article.
125 results